Navigation Links
New York Times Best Selling Author Dr. Roy Vartabedian to Endorse New YoNaturals Kids Healthy Vending Program
Date:4/30/2008

YoNaturals, adds that, "This nationwide epidemic of childhood obesity and early-onset-diabetes has attracted attention from parents, lawmakers, and school officials who have become increasingly concerned about the diet of America's school children."

Kids Healthy Vending was inspired by a successful 2007 vending campaign in middle and high schools. Mark Trotter explains that, "Last year's program encouraged us to expand upon it in 2008 as a pilot initiative which has now become the cornerstone for Kids Healthy Vending." Trotter adds that, "Another far-reaching effort that we are committed to exceeding with Kids Healthy Vending involves California Senate Bill 19 (SB19), which sets the nutritional standards for food sold in elementary schools. Today the standards set in that policy are used as models for many school districts and states across the U.S. when considering their own reform."

While it is still in the beginning stages of the program's rollout, YoNaturals is already seeing positive feedback from people involved. Kathleen Porterfield, Principal of Encinitas Country Day School, explains that, "Our middle school students are thrilled to have YoNaturals machines on campus, and our parents can share in their happiness because it's healthy!"

Lisa Hawk, of the Preuss School UCSD, adds that, "We love YoNaturals vending options, the food is not only tasty, but so healthy, and students swarm the machines during lunch and after school."

"The national launch of Kids Healthy Vending is slated for May 5th, a time when many schools districts across the U.S. begin making decisions for the following year. Trotter explains that, "We are looking for both public and private schools that want to adapt to our Kids Healthy Vending program and also have programs in place allowing the schools themselves to purchase our machines, order our products on line and receive one hundred percent of the profits themselves."

With support through the program's
'/>"/>

SOURCE YoNaturals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. African Americans have 5 times higher amputation rate
2. Los Angeles Times writer wins Wistar Institute Science Journalism Award
3. PCMA Response to New York Times Article on Biotech Medicine Costs
4. Report: Life And Death Differences in U.S. Child Well-Being Exist Between Top and Bottom States, Youths Up to Three Times More Likely to Die Before Adulthood in Some Parts of U.S.
5. Statement from Eli Lilly and Company: Response to Todays New York Times Article, Lilly E-Mail Discussed Off-Label Drug Use
6. Prescription costs rise more than 6 times when patients reach 65 says study of 5M people
7. Mardi Gras Means Lean Times Ahead But That Doesnt Mean the Partys Over
8. The best of times and the worst of times: Sustaining the future of academic GI
9. Protecting Productivity at the Worksite in Challenging Times
10. ER Wait Times Getting Longer
11. Foundation Radiology Group Formalizes Strategic Partnership with Emageon to Provide Advanced Imaging Software to Facilitate Industry-Leading Turnaround and Patient Care Response Times
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...ngland register the lowest number of early deaths ...ls of obesity and the longest life expectancy. By...s the lowest life expectancy for men. Near neighbo...men. Those in both cities live, on average, near...
...ng the link between levels of urate in the blood a...the Harvard School of Public Health (HSPH) have fo...ted with a reduced risk of the disease. Urate is...ugh high levels can lead to gout, urate might also...
...er for three years. Circuit Judge Weber McCraw, wh...r the option of serving some of her sentence in a...nnessee preacher told the Jurors presiding over he... shot her husband. She had been suffering domestic...
...patients who have recently suffered a major heart ...rom their own bone marrow during routine coronary...her the stem cells will repair heart muscle cells ...ing late scar formation and hence impaired heart c...
Other Medicine News:Health News:Southern England Far Healthier Than the North 2Health News:Urate Reduces the Risk of Parkinsons Disease 2Health News:Domestic Abuse Led Wife Killing Her Preacher Husband 2Health News:A New Milestone in Stem Cell Research 2
(Date:8/27/2008)...tients in the VELCADE, melphalan and prednisone ar... well as a 30 percent complete response -, CAMBRI...e Takeda,Oncology Company today announced the publ...d, Phase III VISTA(1) trial in this week,s edition...ts showed a significant survival,benefit and a 30 ...
(Date:8/27/2008)...First Phase 3 data, from BLISS-52 trial, expected ...LISS-76, expected by fall 2009 -, ROCKVILLE, Md.,...iences, Inc. (Nasdaq: HGSI ) today announced it h...S-76, the second of two pivotal Phase 3,randomized... patients with,active systemic lupus erythematosus...
(Date:8/26/2008)...IANAPOLIS, Aug. 26 /- Semafore Pharma...national Congress on Targeted Therapies,in Cancer ...ovel,multi-targeted kinase inhibitors that demonst...l studies., A novel and proprietary molecular sca...ing allowing for the design of pan-PI3 kinase inhi...
(Date:8/26/2008)...LO PARK, Calif., Aug. 26 /-... the positive one-year follow-up data,from the CUS...e of the,peer-reviewed journal, EuroIntervention. ...tella, M.D., of University Medical Center Utrecht,...II Investigators from 13 clinical,sites across Eur...
Breaking Medicine Technology:New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Blood pressure drug telmisartan shows powerful activity against stroke 1570 1Blood pressure drug telmisartan shows powerful activity against stroke 1570 2Blood pressure drug telmisartan shows powerful activity against stroke 1570 3Ireland Cancer Center researchers advance stem cell gene therapy 1565 1Ireland Cancer Center researchers advance stem cell gene therapy 1565 2Ireland Cancer Center researchers advance stem cell gene therapy 1565 3Wind power explored off Californias coast 1563 1Wind power explored off Californias coast 1563 2Wind power explored off Californias coast 1563 3Wind power explored off Californias coast 1563 4Ceregene Presents Long term Follow up From Phase 1 Trial of CERE 120 in Parkinsons Disease 1050 1Ceregene Presents Long term Follow up From Phase 1 Trial of CERE 120 in Parkinsons Disease 1050 2Ceregene Presents Long term Follow up From Phase 1 Trial of CERE 120 in Parkinsons Disease 1050 3Ceregene Presents Long term Follow up From Phase 1 Trial of CERE 120 in Parkinsons Disease 1050 4
The PachPen uses state-of-the-art waveform analysis and a probe that samples at a 65MHz rate to obtain precise readings. The PachPen stores and averages nine measurements and calculates IOP correctio
...ailable as both regular and filter tips. Sterilize...re efficient sterilization and are delivered with ...e of irradiation. Sterilized Diamond Tips are read...k Diamond Tips are wrapped in medical device quali...
300 L, Bulk Recommended for 250 and 300 L pipettes.
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio
Medicine Products: